US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GRAIL, Inc.

143.26

+10.708.07%

Post-market: 143.430.1742+0.12%19:59 EDT

Volume:875.34K

Turnover:123.26M

Market Cap:6.40B

PE:-14.70

High:143.50

Open:135.52

Low:134.45

Close:132.56

52wk High:151.46

52wk Low:41.50

Shares:44.67M

Float Shares:40.70M

Volume Ratio:0.69

T/O Rate:2.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.7487

EPS(LYR):-11.1105

ROE:-16.12%

ROA:-12.03%

PB:2.52

PE(LYR):-12.89

Loading ...

Overview Company News Filings

PRESS Digest -Wall Street Journal - September 24

Canaccord Genuity Remains a Buy on GRAIL Inc (GRAL)

RBC Capital Sticks to Their Hold Rating for GRAIL Inc (GRAL)

Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval

FDA panel votes in favor of Grail’s Galleri benefits outweighing risks

US FDA Advisers Back Safety of Grail's Galleri Multi-Cancer Screening Test

THOMSON REUTERS

FDA panel says Grail’s cancer detection blood test is safe, Bloomberg says

Grail CEO Joshua J. Ofman Disposes of Common Shares Worth $5.54 Million

FDA Advisers are Reviewing a Multicancer-Detection Test. Medicare Coverage Could Follow.

Grail Trading Halted Ahead of FDA AdCom Meeting on Galleri Blood Test

NASDAQ Trade Halt Halt News Pending at 06:55 Am

With Approval Looking Likely, How Fast Will Sales of Cancer-Screening Blood Tests Rise?

Grail Gains From More Focused FDA Review Before Galleri Advisory Panel, UBS Says

MT Newswires Live

Canaccord Genuity Remains a Buy on GRAIL Inc (GRAL)

Under the Radar: Grail Shares Surge on FDA Results

Grail Shares Jump 34.6% as US FDA Flags no Major Concerns for Co's Cancer Test

THOMSON REUTERS

Grail Stock Soars 33% Ahead of Multi-Cancer Blood Test Review from FDA

Grail rallies after FDA releases briefing documents for Galleri test review

Grail rises 23.2%

GRAIL Risk-Reward Attractive Ahead of FDA Advisory Committee, UBS Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/GRAL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":143.26,"timestamp":1790971200000,"preClose":132.56,"halted":0,"volume":875335,"hourTrading":{"tag":"盘后","latestPrice":143.4342,"preClose":143.26,"latestTime":"19:59 EDT","volume":20668,"amount":2958908.1789,"timestamp":1790985589395,"change":0.1742,"changeRate":0.001216,"amplitude":0.016066},"delay":0,"changeRate":0.08071816535908259,"floatShares":40696402,"shares":44666200,"eps":-9.748709,"marketStatus":"Market Closed","change":10.7,"latestTime":"10-02 16:00:00 EDT","open":135.52,"high":143.5,"low":134.45,"amount":123255728.77629998,"amplitude":0.068271,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.748709,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":132.56,"preHourTrading":{"tag":"盘前","latestPrice":135.7719,"preClose":132.56,"latestTime":"09:24 EDT","volume":1153,"amount":155671.68391,"timestamp":1790947487905,"change":3.2119,"changeRate":0.02423,"amplitude":0.049487},"postHourTrading":{"tag":"盘后","latestPrice":143.4342,"preClose":143.26,"latestTime":"19:59 EDT","volume":20668,"amount":2958908.1789,"timestamp":1790985589395,"change":0.1742,"changeRate":0.001216,"amplitude":0.016066},"volumeRatio":0.690371,"impliedVol":0.8636,"impliedVolPercentile":0.2032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":40696402,"roa":"-12.03%","roe":"-16.12%","lyrEps":-11.110457,"volumeRatio":0.690371,"shares":44666200,"dividePrice":0,"high":143.5,"amplitude":0.068271,"preClose":132.56,"low":134.45,"week52Low":41.5,"pbRate":"2.52","psRate":"38.72","week52High":151.4574,"institutionHeld":0,"latestPrice":143.26,"eps":-9.748709,"divideRate":0,"volume":875335,"delay":0,"ttmEps":-9.748709,"open":135.52,"prevYearClose":85.59,"prevWeekClose":126.89,"prevMonthClose":140.12,"prevQuarterClose":140.12,"fiveDayClose":126.89,"twentyDayClose":80.62,"sixtyDayClose":75.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"GRAL","fiscalQuarterEnding":"2026/06","expectedEps":-2.91,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-2.56},{"market":"US","date":"2026-05-05","symbol":"GRAL","fiscalQuarterEnding":"2026/03","expectedEps":3,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2026-02-19","symbol":"GRAL","fiscalQuarterEnding":"2025/12","expectedEps":-3.33,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2025-11-12","symbol":"GRAL","fiscalQuarterEnding":"2025/09","expectedEps":-3.4,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-2.46},{"market":"US","date":"2025-08-12","symbol":"GRAL","fiscalQuarterEnding":"2025/06","expectedEps":-3.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-3.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1818,"buy":0.2727,"hold":0.5455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2727,"analysts":11,"updateTime":1789704000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2026-10-01","current":-14.695279,"percent":0,"low":-15.982739,"twenty":-7.790286,"median":-2.679464,"eighty":-0.304176,"high":-0.135365,"avg":-3.853415,"sd":3.754563,"marketCap":6258632708},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278},{"date":"2025-06-13","current":-0.787758,"twenty":-0.602918,"median":-0.308322,"eighty":-0.156041,"marketCap":1508008868},{"date":"2025-06-20","current":-0.910282,"twenty":-0.617043,"median":-0.310838,"eighty":-0.156127,"marketCap":1742556049},{"date":"2025-06-27","current":-0.927946,"twenty":-0.628237,"median":-0.313683,"eighty":-0.156967,"marketCap":1776371133},{"date":"2025-07-03","current":-0.87796,"twenty":-0.640897,"median":-0.324667,"eighty":-0.158949,"marketCap":1680681639},{"date":"2025-07-11","current":-0.815382,"twenty":-0.656882,"median":-0.33641,"eighty":-0.159595,"marketCap":1560889904},{"date":"2025-07-18","current":-0.675007,"twenty":-0.694504,"median":-0.351643,"eighty":-0.160456,"marketCap":1292167904},{"date":"2025-07-25","current":-0.746416,"twenty":-0.703946,"median":-0.35847,"eighty":-0.160672,"marketCap":1428867181},{"date":"2025-08-01","current":-0.642872,"twenty":-0.704698,"median":-0.372061,"eighty":-0.161318,"marketCap":1230653229},{"date":"2025-08-08","current":-0.619382,"twenty":-0.703946,"median":-0.384644,"eighty":-0.164764,"marketCap":1185686362},{"date":"2025-08-15","current":-2.618835,"twenty":-0.718416,"median":-0.412102,"eighty":-0.165733,"marketCap":1160018171},{"date":"2025-08-22","current":-2.697774,"twenty":-0.721799,"median":-0.415789,"eighty":-0.165949,"marketCap":1194984536},{"date":"2025-08-29","current":-2.7759,"twenty":-0.732698,"median":-0.419718,"eighty":-0.170579,"marketCap":1229590423},{"date":"2025-09-05","current":-2.733582,"twenty":-0.742958,"median":-0.427076,"eighty":-0.170837,"marketCap":1210845568},{"date":"2025-09-12","current":-3.145369,"twenty":-0.751941,"median":-0.435395,"eighty":-0.172539,"marketCap":1393247431},{"date":"2025-09-19","current":-3.221867,"twenty":-0.757193,"median":-0.443129,"eighty":-0.177083,"marketCap":1427132362},{"date":"2025-09-26","current":-3.927439,"twenty":-0.772199,"median":-0.450236,"eighty":-0.179927,"marketCap":1739666779},{"date":"2025-10-03","current":-5.267781,"twenty":-0.790326,"median":-0.453995,"eighty":-0.180724,"marketCap":2333374029},{"date":"2025-10-10","current":-5.788618,"twenty":-0.792794,"median":-0.466707,"eighty":-0.18193,"marketCap":2564079942},{"date":"2025-10-17","current":-7.032117,"twenty":-0.810572,"median":-0.474733,"eighty":-0.214168,"marketCap":3114890311},{"date":"2025-10-24","current":-6.726125,"twenty":-0.834423,"median":-0.483801,"eighty":-0.232186,"marketCap":2979350587},{"date":"2025-10-31","current":-7.417862,"twenty":-0.86879,"median":-0.497307,"eighty":-0.23482,"marketCap":3285756878},{"date":"2025-11-07","current":-6.515349,"twenty":-0.90953,"median":-0.508594,"eighty":-0.23627,"marketCap":2885986787},{"date":"2025-11-14","current":-7.32206,"twenty":-1.284423,"median":-0.515869,"eighty":-0.238888,"marketCap":3243320953},{"date":"2025-11-21","current":-8.218834,"twenty":-2.622741,"median":-0.524768,"eighty":-0.242438,"marketCap":3338827399},{"date":"2025-11-28","current":-10.592844,"twenty":-2.668803,"median":-0.533066,"eighty":-0.245748,"marketCap":4303247596},{"date":"2025-12-05","current":-10.047321,"twenty":-2.733908,"median":-0.545714,"eighty":-0.248685,"marketCap":4081633659},{"date":"2025-12-12","current":-9.121802,"twenty":-2.773947,"median":-0.559678,"eighty":-0.249586,"marketCap":3705650118},{"date":"2025-12-19","current":-8.474563,"twenty":-3.023948,"median":-0.565758,"eighty":-0.250383,"marketCap":3442715024},{"date":"2025-12-26","current":-8.814736,"twenty":-3.115583,"median":-0.600672,"eighty":-0.254281,"marketCap":3580907004},{"date":"2026-01-02","current":-8.213077,"twenty":-3.191837,"median":-0.607471,"eighty":-0.259493,"marketCap":3336488466},{"date":"2026-01-09","current":-9.407758,"twenty":-3.756539,"median":-0.615248,"eighty":-0.260321,"marketCap":3821817142},{"date":"2026-01-16","current":-9.350183,"twenty":-4.63773,"median":-0.618067,"eighty":-0.262044,"marketCap":3798427809},{"date":"2026-01-23","current":-11.136928,"twenty":-5.050494,"median":-0.621638,"eighty":-0.262589,"marketCap":4524276801},{"date":"2026-01-30","current":-9.689876,"twenty":-5.381714,"median":-0.623725,"eighty":-0.263657,"marketCap":3936424878},{"date":"2026-02-06","current":-9.025844,"twenty":-5.92371,"median":-0.62862,"eighty":-0.266328,"marketCap":3666667895},{"date":"2026-02-13","current":-9.201448,"twenty":-6.490935,"median":-0.634416,"eighty":-0.269888,"marketCap":3738005363},{"date":"2026-02-20","current":-10.027753,"twenty":-6.738169,"median":-0.640672,"eighty":-0.270458,"marketCap":4094842980},{"date":"2026-02-27","current":-5.738328,"twenty":-6.59852,"median":-0.642551,"eighty":-0.271707,"marketCap":2343252016},{"date":"2026-03-06","current":-5.1161,"twenty":-6.525603,"median":-0.645131,"eighty":-0.273298,"marketCap":2089164448},{"date":"2026-03-13","current":-4.454105,"twenty":-6.495818,"median":-0.656882,"eighty":-0.273627,"marketCap":1818838106},{"date":"2026-03-20","current":-4.868977,"twenty":-6.467497,"median":-0.678025,"eighty":-0.275336,"marketCap":1988251759},{"date":"2026-03-27","current":-5.23965,"twenty":-6.370491,"median":-0.694504,"eighty":-0.275763,"marketCap":2139616500},{"date":"2026-04-02","current":-5.384303,"twenty":-6.22661,"median":-0.703946,"eighty":-0.276019,"marketCap":2198685668},{"date":"2026-04-10","current":-4.777565,"twenty":-6.012578,"median":-0.718792,"eighty":-0.276332,"marketCap":1950923327},{"date":"2026-04-17","current":-4.969431,"twenty":-5.842655,"median":-0.720859,"eighty":-0.277189,"marketCap":2029272014},{"date":"2026-04-24","current":-5.087966,"twenty":-5.758444,"median":-0.724241,"eighty":-0.277697,"marketCap":2077675915},{"date":"2026-05-01","current":-5.472702,"twenty":-5.73481,"median":-0.732698,"eighty":-0.277887,"marketCap":2234783492},{"date":"2026-05-08","current":-6.830613,"twenty":-5.758444,"median":-0.740497,"eighty":-0.278585,"marketCap":2700312031},{"date":"2026-05-15","current":-6.709025,"twenty":-6.393277,"median":-0.747877,"eighty":-0.279728,"marketCap":2652245447},{"date":"2026-05-22","current":-7.366901,"twenty":-6.535065,"median":-0.752054,"eighty":-0.280426,"marketCap":2912320000},{"date":"2026-05-29","current":-8.024776,"twenty":-6.608933,"median":-0.75506,"eighty":-0.280871,"marketCap":3172394554},{"date":"2026-06-05","current":-7.224687,"twenty":-6.675155,"median":-0.757458,"eighty":-0.282109,"marketCap":2856099264},{"date":"2026-06-12","current":-6.530986,"twenty":-6.667338,"median":-0.770188,"eighty":-0.283378,"marketCap":2581862234},{"date":"2026-06-18","current":-6.453909,"twenty":-6.64758,"median":-0.774322,"eighty":-0.283727,"marketCap":2551391453},{"date":"2026-06-26","current":-7.226858,"twenty":-6.705551,"median":-0.790201,"eighty":-0.284901,"marketCap":2856957596},{"date":"2026-07-02","current":-7.394041,"twenty":-6.741593,"median":-0.791697,"eighty":-0.287059,"marketCap":2923049149},{"date":"2026-07-10","current":-8.227784,"twenty":-6.830613,"median":-0.793866,"eighty":-0.287218,"marketCap":3252648583},{"date":"2026-07-17","current":-7.811998,"twenty":-6.920316,"median":-0.805047,"eighty":-0.287691,"marketCap":3088278032},{"date":"2026-07-24","current":-7.638301,"twenty":-7.010823,"median":-0.819893,"eighty":-0.291185,"marketCap":3019611483},{"date":"2026-07-31","current":-7.722978,"twenty":-7.028862,"median":-0.830133,"eighty":-0.292962,"marketCap":3053086426},{"date":"2026-08-07","current":-7.231699,"twenty":-7.225121,"median":-0.842819,"eighty":-0.294422,"marketCap":2831839235},{"date":"2026-08-14","current":-7.783772,"twenty":-7.278539,"median":-0.870399,"eighty":-0.295212,"marketCap":3048023808},{"date":"2026-08-21","current":-8.893621,"twenty":-7.372329,"median":-0.87796,"eighty":-0.295699,"marketCap":3482626264},{"date":"2026-08-28","current":-9.410334,"twenty":-7.428129,"median":-0.917705,"eighty":-0.296146,"marketCap":3684964305},{"date":"2026-09-04","current":-9.195892,"twenty":-7.480979,"median":-0.966282,"eighty":-0.297019,"marketCap":3600991785},{"date":"2026-09-11","current":-8.846854,"twenty":-7.492831,"median":-2.572448,"eighty":-0.297976,"marketCap":3464313109},{"date":"2026-09-18","current":-9.119469,"twenty":-7.639447,"median":-2.628601,"eighty":-0.298484,"marketCap":3571065408},{"date":"2026-09-25","current":-14.282035,"twenty":-7.746291,"median":-2.668477,"eighty":-0.301515,"marketCap":5592659159},{"date":"2026-10-01","current":-15.982739,"twenty":-7.790286,"median":-2.679464,"eighty":-0.304176,"marketCap":6258632708}],"updateTime":1790985174992},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669451354","title":"PRESS Digest -Wall Street Journal - September 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451354","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669451354?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:21","pubTimestamp":1790227304,"startTime":"0","endTime":"0","summary":"PRESS DIGEST -Wall Street Journal - September 24The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.- Barry Diller on Wednesday said he is withdrawing his bid for MGM ResortsMGM.Nafter months of discussions with the company.- An OpenAI agent infiltrated a government-services website in Australia this summer, Prime Minister Anthony Albanese said Wednesday at the United Nations meeting in New York.- Grail Inc.GRAL.Oreceived a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test.- Activist investor Starboard Value has taken a significant stake in construction company Knife RiverKNF.N, with plans to push the company to improve its margins or explore a sale.- Florida’s high-speed railroad Brightline is planning an imminent chapter 11 bankruptcy filing in New Jersey to restructure about $5.5 billion in debt.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G07V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODDZ","LU1571399168.USD","BK4585","BK4588","GRAL","BK4139","BK4561","MGM","BK4011","BK4150","KNF","LU1559883803.SGD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669456881","title":"Canaccord Genuity Remains a Buy on GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669456881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669456881?lang=en_us&edition=fundamental","pubTime":"2026-09-24 11:35","pubTimestamp":1790220914,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Kyle Mikson CFA reiterated a Buy rating on GRAIL Inc today and set a price target of $80.00. Mikson CFA covers the Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-grail-inc-gral-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-grail-inc-gral-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139","CFA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669289458","title":"RBC Capital Sticks to Their Hold Rating for GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669289458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669289458?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:45","pubTimestamp":1790214339,"startTime":"0","endTime":"0","summary":"In a report released on September 21, Dan Leonard from RBC Capital maintained a Hold rating on GRAIL Inc, with a price target of $84.00. The compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-hold-rating-for-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-hold-rating-for-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431216","title":"Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431216","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431216?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:35","pubTimestamp":1790202900,"startTime":"0","endTime":"0","summary":"Grail Inc. received a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test.The cancer-detection company said the FDA's medical devices advisory committee voted 7-2, with one abstention, to greenlight a premarket approval application for Galleri.The FDA isn't bound to the committee's recommendation, but it takes them into consideration when making the final regulatory decision. The FDA is expected to make its final ruling on Galleri's premarket approval in the coming months.In three separate votes, the 10 voting members of the committee considered Galleri's safety, effectiveness and overall benefit-risk profile for screening and early detection of multiple types of cancer in adults aged 50 and older.The Galleri test is designed to detect cancer-specific methylation patterns shared by many types of cancer before symptoms appear, including cancers that don't have recommended screening today.When a cancer si","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4588","BK4585","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669319284","title":"FDA panel votes in favor of Grail’s Galleri benefits outweighing risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669319284","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669319284?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:10","pubTimestamp":1790201424,"startTime":"0","endTime":"0","summary":"The FDA’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee voted to recommend approval for Grail’s (GRAL) Galleri, a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-panel-votes-in-favor-of-grails-galleri-benefits-outweighing-risks-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-panel-votes-in-favor-of-grails-galleri-benefits-outweighing-risks-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669397114","title":"US FDA Advisers Back Safety of Grail's Galleri Multi-Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2669397114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669397114?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:31","pubTimestamp":1790199110,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0W4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431891","title":"FDA panel says Grail’s cancer detection blood test is safe, Bloomberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431891","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431891?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:30","pubTimestamp":1790199013,"startTime":"0","endTime":"0","summary":"17:26 EDT FDA panel says Grail’s (GRAL) cancer detection blood test is safe, Bloomberg says Published first on TheFly – the ultimate source for rea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-panel-says-grails-cancer-detection-blood-test-is-safe-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-panel-says-grails-cancer-detection-blood-test-is-safe-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4588","LABU","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669223436","title":"Grail CEO Joshua J. Ofman Disposes of Common Shares Worth $5.54 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669223436","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669223436?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:37","pubTimestamp":1790195863,"startTime":"0","endTime":"0","summary":"Grail CEO Joshua J. Ofman disposes of common shares worth $5.54 millionGrail CEO Joshua J. Ofman sold 61,452 common shares on Sep. 21, 2026, cutting his stake to 362,271 shares.Sales priced between US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL4n4Sgc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Grail CEO Joshua J. Ofman Disposes of Common Shares Worth $5.54 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669485793","title":"FDA Advisers are Reviewing a Multicancer-Detection Test. Medicare Coverage Could Follow.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669485793","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669485793?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:39","pubTimestamp":1790167140,"startTime":"0","endTime":"0","summary":"Grail's Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancersGrail sells the Galleri test, which screens for 50 types of cancer usi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669835544","title":"Grail Trading Halted Ahead of FDA AdCom Meeting on Galleri Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2669835544","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669835544?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:52","pubTimestamp":1790164320,"startTime":"0","endTime":"0","summary":"Trading in shares of Grail is halted on Wednesday ahead of a Food and Drug Administration advisory committee meeting to discuss the diagnostic company's proposed multi-cancer blood test.Grail is seeking FDA approval of Galleri, a blood test that aims to catch cancers before symptoms appear.Shares of the Menlo Park, Calif., company were up 34% this week through Tuesday's close after FDA briefing documents for the meeting, released on Monday, were more favorable than investors had expected.RBC Capital Markets analyst Dan Leonard said the briefing documents suggest the FDA is less concerned with Galleri's safety and effectiveness and more focused on how to label the commercial product.The FDA often turns to advisory committees to obtain advice from experts who work outside of the government when a scientific, technical or policy question arises, such as whether an unapproved product is safe and effective. The agency usually follows the advice of its advisory committees but it isn't bound ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU","BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669005631","title":"NASDAQ Trade Halt Halt News Pending at 06:55 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2669005631","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669005631?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:55","pubTimestamp":1790160900,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 06:55 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nAQN2MKEO5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669318122","title":"With Approval Looking Likely, How Fast Will Sales of Cancer-Screening Blood Tests Rise?","url":"https://stock-news.laohu8.com/highlight/detail?id=2669318122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669318122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:10","pubTimestamp":1790107800,"startTime":"0","endTime":"0","summary":"This week's 35% jump in the stock of Grail pretty much prices in a positive vote Wednesday, when outside experts meet with the Food and Drug Administration to advise it on approving the first blood test for many kinds of cancer.With Grail now valued at $4.3 billion, or 19 times the consensus estimate for next year's sales, the stock already seems to be assuming the FDA will approve the test sometime early next year.Both those outcomes look likely. The advance questions posted Monday by the FDA for its advisors focus on the claims Grail should make in marketing its Galleri test to Americans over 50. The agency didn't question the test's safety and accuracy.Labs are permitted to sell tests they develop themselves. Grail is already selling Galleri, but the test is rarely covered by insurance. Last year, Grail had sales of about $150 million.Now the question for investors becomes what kind of sales boost will an approval deliver to Galleri?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","SG9999002224.SGD","LU2211815571.USD","LU0208291251.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","TMED","LU1989763690.USD","LU0266013472.USD","LU2112291526.USD","SGXZ41872573.SGD","SGXZ23171101.USD","LU1989763427.SGD","LU1023059063.AUD","BK4585","LU0882574055.USD","GRAL","BK4139","LU1983299246.USD","PJP","LU2133065610.SGD","LU1914381329.SGD","ABT","LU1691799644.USD","LU0211331839.USD","IE00BJT1NW94.SGD","SG9999004303.SGD","LU1057294990.SGD","IHI","LU2237957902.USD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","BK4568","IE00B4R5TH58.HKD","LU0320765489.SGD","LU0114720955.EUR","BK4504","BK4581","LU1061106388.HKD","SG9999002232.USD","LU0122379950.USD","LU1670628061.USD","BK4592","LU2089984988.USD","LU2237957811.SGD","LU0432979614.USD","LU2324357040.USD","LU1721429402.USD","LU1670627923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669512503","title":"Grail Gains From More Focused FDA Review Before Galleri Advisory Panel, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669512503","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669512503?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:26","pubTimestamp":1790094370,"startTime":"0","endTime":"0","summary":"Grail  faces an \"incrementally positive\" shift toward a narrower and more focused Food and Drug Administration debate ahead of Wednesday's advisory committee meeting on Galleri, its multicancer early detection test, UBS Securities said in a report.The FDA briefing documents show the agency has no major outstanding questions about Galleri's analytical performance, bridging analyses or primary safety results, UBS said Monday in the report. Instead, the panel discussion is expected to center on how the test should be positioned and labeled.A key issue is whether Galleri's stage-specific performance supports an \"early detection\" claim and how broadly any clinical benefit should be reflected in the final indication, the report said. UBS said it still expects FDA approval.UBS reiterated its buy rating on Grail stock with a $105 price target.Price: 108.40, Change: +0.43, Percent Change: +0.40","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","LABU","GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669397143","title":"Canaccord Genuity Remains a Buy on GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669397143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669397143?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:55","pubTimestamp":1790070949,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Kyle Mikson CFA reiterated a Buy rating on GRAIL Inc yesterday and set a price target of $80.00. The company’s shares clo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL","CFA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669556196","title":"Under the Radar: Grail Shares Surge on FDA Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2669556196","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669556196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:57","pubTimestamp":1790031420,"startTime":"0","endTime":"0","summary":"Shares of Grail surged 34% Monday after the Food and Drug Administration released documents ahead of an advisory committee meeting Wednesday that will help determine whether the FDA approves the company's multi-cancer blood test.Galleri looks for chemical tags on DNA that tumors shed into the blood. The test flags a cancer signal and predicts the organ where the cancer is present. Grail has sold it by prescription since 2021, but the FDA has never approved a test that screens for multiple cancers.In a U.S. study of more than 25,000 adults, Galleri wrongly flagged cancer in 0.15% of healthy people. The test missed most cancers. It caught roughly one-third of those diagnosed within a year, in that study and in a U.K. trial of about 142,000 people. In the U.K. trial, it caught 14% of Stage 1 cancers, the earliest stage. The FDA has asked advisers whether those numbers justify calling Galleri an \"early detection\" test.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","GRAL","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669164925","title":"Grail Shares Jump 34.6% as US FDA Flags no Major Concerns for Co's Cancer Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2669164925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669164925?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:40","pubTimestamp":1790005244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669645164","title":"Grail Stock Soars 33% Ahead of Multi-Cancer Blood Test Review from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2669645164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669645164?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:28","pubTimestamp":1790004480,"startTime":"0","endTime":"0","summary":"Shares of Grail soared ahead of the diagnostic company's meeting with the Food and Drug Administration this week to evaluate premarket approval for its landmark blood test designed to spot multiple ty","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","LABU","BK4588","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669164979","title":"Grail rallies after FDA releases briefing documents for Galleri test review","url":"https://stock-news.laohu8.com/highlight/detail?id=2669164979","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669164979?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:20","pubTimestamp":1790004023,"startTime":"0","endTime":"0","summary":"Shares of Grail (GRAL) are up $24.76, or 31%, to $105.53 after the FDA posted briefing documents ahead of the Molecular and Clinical Genetics Panel...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-rallies-after-fda-releases-briefing-documents-for-galleri-test-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-rallies-after-fda-releases-briefing-documents-for-galleri-test-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","GRAL","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669057169","title":"Grail rises 23.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669057169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669057169?lang=en_us&edition=fundamental","pubTime":"2026-09-21 22:06","pubTimestamp":1789999581,"startTime":"0","endTime":"0","summary":"Grail (GRAL) is up 23.2%, or $18.73 to $99.50. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-rises-23-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-rises-23-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668275329","title":"GRAIL Risk-Reward Attractive Ahead of FDA Advisory Committee, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2668275329","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668275329?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:46","pubTimestamp":1789749962,"startTime":"0","endTime":"0","summary":"GRAIL  has an attractive risk-reward profile ahead of the FDA's Sept. 23 advisory committee meeting on its Galleri multi-cancer detection assay, UBS said in a note.UBS said 225 of 227 public comments submitted to the FDA as of Sept. 15 supported approval, while eight called for stricter labeling, clearer cancer-specific performance disclosures and post-market evidence.The bank expects the FDA briefing documents to provide more clarity on the panel's focus. UBS said the safety profile from the PATHFINDER 2 study provides a strong foundation, while the NHS-Galleri trial's failure to meet its primary endpoint is a notable risk.UBS expects FDA approval next year and said a failure to gain approval could leave the stock trading around $40 to $50 per share, while approval could result in a $150 to $170 per share valuation.UBS reiterated a buy rating and $105 price target.Price: 80.52, Change: +0.57, Percent Change: +0.71","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4139","BK4588","GRAL","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":128,"code":"91000000","status":"200"}]}}